|
ZMYM6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.970200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.284100E-02 |
| Normal-vs-Stage2 |
7.129600E-01 |
| Normal-vs-Stage3 |
2.48999999999944E-05 |
| Normal-vs-Stage4 |
2.972300E-04 |
| Stage1-vs-Stage2 |
5.526800E-01 |
| Stage1-vs-Stage3 |
2.422100E-03 |
| Stage1-vs-Stage4 |
1.484150E-03 |
| Stage2-vs-Stage3 |
2.396300E-02 |
| Stage2-vs-Stage4 |
1.810390E-02 |
| Stage3-vs-Stage4 |
8.429200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.773900E-02 |
| Normal-vs-AfricanAmerican |
1.009640E-01 |
| Normal-vs-Asian |
1.865730E-02 |
| Caucasian-vs-AfricanAmerican |
9.955800E-01 |
| Caucasian-vs-Asian |
2.984400E-01 |
| AfricanAmerican-vs-Asian |
3.957400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.695890E-02 |
| Normal-vs-Female |
2.624400E-01 |
| Male-vs-Female |
2.604600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.711550E-02 |
| Normal-vs-Extreme_Weight |
1.658030E-02 |
| Normal-vs-Obese |
6.890400E-02 |
| Normal-vs-Extreme_Obese |
9.569000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.306600E-01 |
| Normal_Weight-vs-Obese |
4.385400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.914550E-01 |
| Extreme_Weight-vs-Obese |
6.884200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.542200E-01 |
| Obese-vs-Extreme_Obese |
3.927800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.181580E-01 |
| Normal-vs-Age(41-60Yrs) |
1.385230E-01 |
| Normal-vs-Age(61-80Yrs) |
2.524300E-02 |
| Normal-vs-Age(81-100Yrs) |
6.260100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.901000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.153000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.926430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.452800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.087840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.676800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.305600E-01 |
| Normal-VS-Type2 PRCC |
2.588100E-04 |
| Normal-VS-KIRP CIMP |
7.179700E-03 |
| Normal-VS-Unclassified PRCC |
8.123800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.046650E-04 |
| Type1 PRCC-VS-KIRP CIMP |
6.552200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.322200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.483600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.012300E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
5.278100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.807200E-04 |
| Normal-vs-N1 |
3.52860000000232E-05 |
| Normal-vs-N2 |
2.283100E-03 |
| N0-vs-N1 |
1.714610E-01 |
| N0-vs-N2 |
9.543600E-02 |
| N1-vs-N2 |
2.453800E-01 |
|
|
